Publication | Closed Access

Ginsenoside Rb1 prevents lipopolysaccharide-induced depressive-like behavior by inhibiting inflammation and neural dysfunction and F2 elicits a novel antidepressant-like effect: A metabolite-based network pharmacology study

InflammationNeural DysfunctionPsychiatryLipopolysaccharide-induced Depressive-like BehaviorMedicineSubcortical Ischemic DepressionDepressionPsychopharmacologyNeuropharmacologyNeuroscienceBiological PsychiatryPharmacologyGinsenoside Rb1Social SciencesOxidative Stress